XLVvsIXJETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) belongs to the US Health Care segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. XLV's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IXJ's top sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.38% for IXJ. XLV is up 11.74% year-to-date (YTD) with +$583M in YTD flows. IXJ performs worse with 8.73% YTD performance, and -$505M in YTD flows. Run a side-by-side ETF comparison of XLV and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs IXJ performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/04/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV IXJ | +5.84%+5.02% | +13.31%+11.19% | +11.74%+8.73% | +26.92%+21.00% | +36.33%+29.78% | +36.64%+26.29% |
| Flows | XLV IXJ | +$374M+$25M | +$699M+$233M | +$583M-$505M | +$2.02B-$256M | -$5.34B-$546M | +$1.95B+$45M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV IXJ | +18.82%+17.59% | +16.03%+15.56% | +14.66%+14.12% | +15.15%+14.50% |
| Max drawdown | XLV IXJ | -3.83%-3.91% | -10.51%-10.83% | -17.05%-18.04% | -17.05%-18.04% |
| Max drawdown duration | XLV IXJ | 20d22d | 116d122d | 444d490d | 444d490d |
Trading data
XLV | IXJ | |
Last sale 9/4/2026 at 1:30 PM | $171.45 | $104.90 |
| Previous close 09/04/2026 | $173.26 | $106.05 |
| Consolidated volume 09/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLV | IXJ | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/4/2026 at 1:30 PM
Live
Closed
XLV | IXJ | |
|---|---|---|
| Last price | $171.45 | $104.90 |
| 1D performance | -1.04% | -1.08% |
| AuM | $44.50 B | $4.31 B |
| E/R | 0.08% | 0.38% |
Characteristics
XLV | IXJ | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | iShares |
| Benchmark | S&P Health Care Select Sector Index | S&P Global 1200 Health Care (Sector) Capped Index |
| N° of holdings | 59 | 110 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | November 13, 2001 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.53%
Other
2.47%
IXJ
USA
69.7%
Switzerland
10.39%
Other
19.91%
Sectors
XLV
Healthcare
97.51%
Other
2.49%
IXJ
Healthcare
97.09%
Other
2.91%
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
71.77%
IXJ
Total weight of top 15 holdings out of 15
56.91%
Top 15 holdings
Data as of July 31, 2026
XLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
IXJ
Eli Lilly & Co.
10.27%
Johnson & Johnson
6.92%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.35%
Merck & Co., Inc.
4.06%
Roche Holding AG
3.89%
Novartis AG
3.64%
AstraZeneca PLC
3.35%
Thermo Fisher Scientific, Inc.
2.71%
Amgen, Inc.
2.65%
Abbott Laboratories
2.33%
Gilead Sciences, Inc.
2.06%
Novo Nordisk A/S
2.05%
Pfizer Inc.
1.80%
CVS Health Corp.
1.70%
Frequently asked questions about XLV and IXJ
How have the XLV and IXJ ETFs performed in 2026?
As of September 4, 2026, XLV is up 11.74% year-to-date (YTD), while IXJ has returned 8.73%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or IXJ?
Year-to-date, the XLV ETF saw +$583M in flows, compared to -$505M for IXJ.
Which ETF is more volatile: XLV or IXJ?
Over the past year, XLV had a volatility of 16.03%, while IXJ experienced 15.56%.
Which ETF is bigger: XLV or IXJ?
As of September 4, 2026, XLV holds $44.50 B in assets under management (AUM), while IXJ manages $4.31 B.
What sectors do the XLV and IXJ ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, IXJ focuses on Healthcare.
What are the top holdings of the XLV ETF and IXJ ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IXJ holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: XLV or IXJ?
XLV holds 59 securities with 71.77% of its assets in the top 15. IXJ has 111 securities and a top 15 weight of 56.91%.
Advertisement
Latest news about XLV & IXJ
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
